Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Liabilities (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Total Liabilities data on record, last reported at $25.9 million in Q3 2023.

  • For Q3 2023, Total Liabilities fell 16.78% year-over-year to $25.9 million; the TTM value through Sep 2023 reached $25.9 million, down 16.78%, while the annual FY2022 figure was $26.1 million, 120.88% up from the prior year.
  • Total Liabilities reached $25.9 million in Q3 2023 per CGEM's latest filing, up from $22.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $62.6 million in Q2 2022 and bottomed at -$106.8 million in Q1 2020.
  • Average Total Liabilities over 4 years is -$1.9 million, with a median of $14.4 million recorded in 2020.
  • Peak YoY movement for Total Liabilities: surged 977.43% in 2022, then plummeted 64.22% in 2023.
  • A 4-year view of Total Liabilities shows it stood at $14.4 million in 2020, then dropped by 17.94% to $11.8 million in 2021, then skyrocketed by 120.88% to $26.1 million in 2022, then fell by 0.76% to $25.9 million in 2023.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $25.9 million in Q3 2023, $22.4 million in Q2 2023, and $29.3 million in Q1 2023.